Go Deep
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,106 | -7.1 | 3.58 | 0.01 | 678.23 |
Eupraxia Pharmaceuticals Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -14,486,955.0 | -12,653,431.0 | -16,711,252.0 | -6,361,367.0 |
| EPS | -0.2 | -0.2 | — | — |
Eupraxia Pharmaceuticals Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -38,576,143.0 | -25,502,536.0 | -28,220,796.0 | -18,489,629.0 | — |
| EPS | -1.0 | -0.8 | -1.2 | -1.0 | — |
Eupraxia Pharmaceuticals Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 86,150,008.0 | 34,942,355.0 | 20,266,229.0 | 19,122,249.0 | — |
| Total Liabilities | 5,703,915.0 | 3,103,386.0 | 19,373,903.0 | 11,914,395.0 | — |
| Total Equity | 82,041,436.0 | 33,404,803.0 | 2,216,207.0 | 7,786,525.0 | — |
Eupraxia Pharmaceuticals Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 93.5%Receivables 0.8%Fixed assets (tangible) 1.1%Other assets 4.6%
How it's funded — Dec 2025
Payables 1.8%Other liabilities 4.7%Shareholders' equity 93.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 80.6 | 33.1 | 19.3 | 18.3 |
| Receivables | 0.7 | 0.2 | 0.2 | 0.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 1.0 | 0.4 | 0.5 | 0.5 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 3.9 | 1.2 | 0.3 | 0.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.1 | 10.4 | 0.1 |
| Long-term debt | 0.1 | 0.0 | 0.0 | 8.8 |
| Payables | 1.5 | 1.5 | 5.0 | 2.4 |
| Other liabilities | 4.0 | 1.5 | 3.9 | 0.6 |
| Shareholders' equity | 80.4 | 31.8 | 0.9 | 7.2 |
| Net tangible assets | 82.0 | 33.4 | 2.2 | 7.8 |
Eupraxia Pharmaceuticals Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -28,552,218.0 | -29,994,491.0 | -20,748,619.0 | -14,395,201.0 | — |
| Investing Activities | -588,947.0 | -75,159.0 | -73,377.0 | 9,834,371.0 | — |
| Financing Activities | 76,058,540.0 | 45,784,207.0 | 21,078,966.0 | 10,801,079.0 | — |